These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36449598)

  • 1. For insights into the real world, consider real-world data.
    Raoof S; Kurzrock R
    Sci Transl Med; 2022 Nov; 14(673):eabn6911. PubMed ID: 36449598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
    Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
    Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial designs using real-world data: The changing landscape of the regulatory approval process.
    Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Evidence Studies of Oritavancin Use in Gram-Positive Infections Augment Randomized Controlled Trials to Address Clinical and Economic Outcomes.
    Redell M
    Drugs Real World Outcomes; 2020 Jun; 7(Suppl 1):2-5. PubMed ID: 32588383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence.
    Lu S; Shih JY; Jang TW; Liam CK; Yu Y
    Adv Ther; 2021 May; 38(5):2038-2053. PubMed ID: 33730350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions.
    Roberts MH; Ferguson GT
    Pharmacoecon Open; 2021 Mar; 5(1):3-11. PubMed ID: 32557235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective.
    Azoulay L
    Oncologist; 2022 Sep; 27(9):e731-e738. PubMed ID: 35762676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020.
    Arondekar B; Duh MS; Bhak RH; DerSarkissian M; Huynh L; Wang K; Wojciehowski J; Wu M; Wornson B; Niyazov A; Demetri GD
    Clin Cancer Res; 2022 Jan; 28(1):27-35. PubMed ID: 34667027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral nerve stimulation for urinary urge incontinence, urgency-frequency, urinary retention, and fecal incontinence: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(3):1-64. PubMed ID: 23074472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Evidence Should Be Used in Regulatory Decisions About New Pharmaceutical and Medical Device Products for Diabetes.
    Klonoff DC; Gutierrez A; Fleming A; Kerr D
    J Diabetes Sci Technol; 2019 Nov; 13(6):995-1000. PubMed ID: 30943790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world evidence in diabetes: relevance to clinical practice.
    Blonde L; Bailey T; Strong J; Levin P
    J Fam Pract; 2019 Apr; 68(3 Suppl):. PubMed ID: 31219479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US Food and Drug Administration.
    Hilal T; Sonbol MB; Prasad V
    JAMA Oncol; 2019 Jun; 5(6):887-892. PubMed ID: 31046071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of real-world evidence to support FDA post-approval study requirements for oncology drugs.
    Zettler ME
    Expert Rev Anticancer Ther; 2022 Jun; 22(6):657-666. PubMed ID: 35512688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema.
    Gabrielle PH; Mehta H; Barthelmes D; Daien V; Nguyen V; Gillies MC; Creuzot-Garcher CP
    Prog Retin Eye Res; 2023 Nov; 97():101219. PubMed ID: 37898362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence.
    Passamonti F; Corrao G; Castellani G; Mora B; Maggioni G; Gale RP; Della Porta MG
    Blood Rev; 2022 Jul; 54():100914. PubMed ID: 34996639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Payer perceptions of the use of real-world evidence in oncology-based decision making.
    Brixner D; Biskupiak J; Oderda G; Burgoyne D; Malone DC; Arondekar B; Niyazov A
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1096-1105. PubMed ID: 34337998
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of collecting structured clinical information on multiple sclerosis.
    Ziemssen T; Hillert J; Butzkueven H
    BMC Med; 2016 May; 14():81. PubMed ID: 27246898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings
.
    Kostev K; Schokker E; Jacob L
    Int J Clin Pharmacol Ther; 2018 Sep; 56(9):411-416. PubMed ID: 30049306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.